ASP2246

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2246, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke [Phase 1, Phase 2]